Table 2.
D10, RBE, and SER in each cell.
| D10 (Gy) | RBE | SER | |
|---|---|---|---|
| HSG | |||
| X-rays | 6.12 | ||
| Proton beams alone | 6.00 | 1.02 | |
| Proton beams with 20 ppm of boron | 5.74 | 1.07 | 1.04 |
| Proton beams with 80 ppm of boron | 4.98 | 1.23 | 1.21 |
| MG63 | |||
| X-rays | 6.33 | ||
| Proton beams alone | 6.29 | 1.01 | |
| Proton beams with 20 ppm of boron | 5.88 | 1.08 | 1.07 |
| Proton beams with 80 ppm of boron | 4.39 | 1.44 | 1.43 |
| SAS | |||
| X-rays | 6.17 | ||
| Proton beams alone | 5.87 | 1.05 | |
| Proton beams with 20 ppm of boron | 5.64 | 1.09 | 1.04 |
| Proton beams with 80 ppm of boron | 4.21 | 1.46 | 1.39 |
| G-361 | |||
| X-rays | 6.74 | ||
| Proton beams alone | 6.47 | 1.04 | |
| Proton beams with 20 ppm of boron | 5.99 | 1.13 | 1.08 |
| Proton beams with 80 ppm of boron | 4.13 | 1.63 | 1.57 |
D10 dose that resulted in a surviving fraction of 10%, G-361 human malignant melanoma cell, HSG human salivary gland tumor cell, MG63 human osteosarcoma cell, RBE relative biological effectiveness, SAS human tongue squamous-cell carcinoma cell, SER sensitizer enhancement ratio.